Dopamine agonists are capable of selectively inhibiting the increased vascular permeability caused by VEGF, thereby reducing the incidence of OHSS without interfering with the outcome of IVF cycles (86). This evidence concerns the gene VEGFA and ovarian hyperstimulation syndrome.